FFA
ANAB icon

Farther Finance Advisors’s AnaptysBio ANAB Stock Holding History

Farther Finance Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.6K Buy
395
+11
+3% +$667 ﹤0.01% 3761
2026
Q1 		$21.8K Hold
384
– – ﹤0.01% 3600
2025
Q4 		$18.6K Buy
384
+109
+40% +$4.25K ﹤0.01% 3503
2025
Q3 		$8.42K Sell
275
-62
-18% -$1.42K ﹤0.01% 3518
2025
Q2 		$7.48K Sell
337
-1,540
-82% -$32.2K ﹤0.01% 3211
2025
Q1 		$34.5K Buy
1,877
+1,858
+9,779% +$31K ﹤0.01% 2093
2024
Q4 		$252 Sell
19
-3
-14% -$73 ﹤0.01% 3600
2024
Q3 		$737 Sell
22
-7
-24% -$239 ﹤0.01% 3323
2024
Q2 		$714 Buy
29
+12
+71% +$279 ﹤0.01% 3177
2024
Q1 		$362 Hold
17
– – ﹤0.01% 3115
2023
Q4 		$364 Buy
17
+1
+6% +$17 ﹤0.01% 3077
2023
Q3 		$287 Hold
16
– – ﹤0.01% 2396
2023
Q2 		$325 Hold
16
– – ﹤0.01% 2263
2023
Q1 		$348 Hold
16
– – ﹤0.01% 2092
2022
Q4 		$496 Buy
+16
New +$452 ﹤0.01% 1830

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Farther Finance Advisors's ANAB Position: Q2 2026 in Review

Farther Finance Advisors increased its AnaptysBio (ANAB) stake by 2.9% in Q2 2026, buying an estimated $667 and bringing the position to 395 shares worth $26.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3761.

Farther Finance Advisors first reported a position in ANAB in Q4 2022 and has held it in 15 quarters since. The position peaked at $34.5K in Q1 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Farther Finance Advisors held 395 shares of AnaptysBio worth $26.6K as of Q2 2026.
  • Farther Finance Advisors bought 11 AnaptysBio shares in Q2 2026, an estimated $667.
  • AnaptysBio made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3761 holding.
  • Farther Finance Advisors first reported a position in AnaptysBio in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's AnaptysBio position peaked at $34.5K in Q1 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.